Navigation Links
Cell Biosciences Acquires Protein Forest
Date:12/7/2009

SANTA CLARA, Calif., Dec. 7 /PRNewswire/ -- Cell Biosciences, Inc. today announced that it has acquired Protein Forest, Inc. of Lexington, Massachusetts, a leader in sample preparation technology for proteomic analysis and biomarker discovery. This strategic acquisition adds Protein Forest's novel digital ProteomeChip(TM) product line to Cell Biosciences' expanding portfolio of innovative products for protein analysis.

Protein Forest, founded in 2002, pioneered a new technology for rapid, highly reproducible protein fractionation of complex biological samples - an important prerequisite step for quantitative proteomics measurements. The technology can be used as a sample preparation front-end for many protein analysis techniques, including western blot analysis, mass spectrometry, and the Cell Biosciences' nanoproteomic platforms. The digital ProteomeChip product line includes instrumentation, software, reagents, and proprietary consumables.

Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. The company's products include novel nanofluidic assay systems for ultrasensitive protein analysis, and a complete line of leading digital imaging systems for proteomic and genomic research. Cell Biosciences has approximately 100 employees in North America, Europe and Asia, and its products are sold in more than 40 countries.

Commenting on the transaction, Tim Harkness, President and Chief Executive Officer of Cell Biosciences, said, "This acquisition adds an exciting sample preparation product line to our growing protein analysis business. The lack of reproducible sample preparation has become a serious problem for proteomics researchers. We believe that the digital ProteomeChip products represent a powerful solution for this market need. The digital ProteomeChip product line fits perfectly with our strategic plan and will be leveraged immediately by our global distribution organization."

In connection with the all-stock acquisition, Cell Biosciences raised an additional $4 million in an equity financing, led by Novo A/S.

ABOUT CELL BIOSCIENCES

Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. The Company develops instrumentation systems, sample preparation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine. With an installed base of over 10,000 systems, its customers include leading research institutions, pharmaceutical and biotechnology companies worldwide. Cell Biosciences is headquartered in Santa Clara, California. For more information, visit www.cellbiosciences.com.

SOURCE Cell Biosciences, Inc.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.
2. Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops
3. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
4. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
5. American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
6. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
7. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
8. Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
9. YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
10. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009
11. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
Breaking Biology News(10 mins):